查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827920

植物基因体学市场按产品类型、技术、服务模式、应用和最终用户划分－2025-2032 年全球预测

Plant Genomics Market by Product Type, Technology, Service Model, Application, End Users - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年植物基因组学市场将成长至 230.9 亿美元，复合年增长率为 9.50%。

主要市场统计数据
基准年2024年 111.6亿美元
预计2025年 122.3亿美元
预测年份：2032年 230.9亿美元
复合年增长率（%） 9.50%

植物基因组学策略入门指南，涵盖农业、诊断和研究领域的技术整合、业务重点和相关人员需求

植物基因组学处于生物学、资料科学和农业创新的交叉点，其不断扩展的套件正在重新定义相关人员追求生产力、韧性和诊断洞察力的方式。编辑平台、扩增和定序技术的进步正在逐步降低技术壁垒，使更广泛的组织能够将基因组学整合到育种计划、诊断工作流程和基础研究中。随着这种转变，对资料管理、可重复性和监管清晰度的日益重视正在塑造整个价值链的投资重点和营运选择。

随着该领域的成熟，研究人员需要应对日益复杂的供应商网络、不断发展的基因工具部署标准以及对稳健生物资讯流程日益增长的需求。为此，多学科团队正在围绕模组化工作流程进行重组，以连接仪器、试剂、分析软体和服务。这种整合方法提高了通量和可解释性，同时也凸显了对灵活筹资策略和熟练人才的需求，这些人才能够将基因组学成果转化为农业、诊断和探索研究的可行决策。

技术突破、不断变化的监管预期以及以服务为中心的模式如何重塑植物基因组学研究的策略重点和营运工作流程

在方法学突破、监管格局变化以及终端用户期望不断提升的推动下，植物基因组学领域正在经历一场变革性转变。基因编辑技术正从利基实验工具转变为性状开发的实用工具，促使下游育种策略和智慧财产权管理做出调整。同时，定序平台提供的资料集越来越丰富、越来越复杂，因此需要对可扩展储存、标准化资料格式以及支援交叉研究比较和转换应用的分析框架进行投资。

同时，企业越来越重视成果而非内部设备，这导致了向服务和软体的转变。这一趋势正在推动将专业湿实验室能力与先进运算能力相结合的协作模式。供应链弹性和采购透明度正在推动人们重新思考采购惯例。这些因素共同深刻地改变了企业分配资本、设计实验和建立伙伴关係的方式。

评估近期关税行动对植物基因组学工作流程中的采购、协作和供应连续性的营运和物流影响

近期影响进出口的关税措施为植物基因组学生态系统带来了新的摩擦，影响了设备、试剂和软体许可证的采购。对于依赖跨境定序设备和专用试剂供应的实验室来说，与关税相关的成本调整可能会导致采购计画和资本计画的调整。这些变化可能会影响实验室的吞吐量和新计画的启动速度，尤其对于那些按照津贴週期和季节性农业时间表运作的研究机构。

除了直接的成本影响外，关税还可能使依赖样品、耗材和模组化仪器组件及时运输的合作研究安排变得复杂。因此，越来越多的团队正在考虑本地采购替代方案、延长前置作业时间以及合约保障措施，以保持研究的连续性。贸易措施也提高了一些相关人员为降低风险而采取的本地製造和分销策略的知名度。重要的是，与关税引入相关的监管和海关流程可能会增加生物材料和硬体的清关时间。

深度细分洞察揭示了产品类型、技术平台、服务模式、应用和最终用户如何在植物基因组学中创造差异化的价值池

对市场区隔的细緻理解，能够揭示价值创造点以及哪些能力值得投资。相关人员根据产品类型将市场分为仪器、试剂和耗材、服务和软体，每种类型都有不同的采购週期和支援预期。仪器需要资本规划和长期服务合同，试剂和耗材会带来经常性支出和品管问题，服务为缺乏内部能力的实验室提供以结果为导向的能力，软体则支援数据处理、可视化和决策支援。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • CRISPR-Cas介导的基因编辑技术进展使耐旱作物品种能够适应气候
  • 整合人工智慧和机器学习，加速植物性状发现过程
  • 开发用于分析植物压力反应的高通量单细胞定序平台
  • 商业化精准基因编辑技术以提高作物产量和营养价值
  • 泛基因组分析揭示主要谷物作物的遗传多样性
  • 应用标靶表观基因编辑工具控制植物生长和环境耐受性
  • 利用综合多组体学资料预测育种计划中复杂性状的遗传
  • 扩大合成生物学方法以提高主要作物的光合作用效率
  • 可携式奈米孔定序系统在农业领域即时病原体检测的应用
  • 影响基因改造植物产品接受度的全球监管协调努力

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：植物基因体学市场（依产品类型）

  • 装置
  • 试剂和耗材
  • 服务
  • 软体

第九章植物基因体学市场（依技术）

  • 基因编辑
    • CRISPR
    • 转录活化因子样效应核酸酶
    • 锌指核酸酶
  • 聚合酵素链锁反应
    • 数位聚合酵素链锁反应
    • 定量聚合酵素链锁反应
    • 逆转录聚合酵素链锁反应
  • 定序
    • 次世代定序
    • 桑格定序
    • 第三代定序

第 10 章：植物基因体学市场（依服务模式）

  • 咨询
  • 合约调查
  • 数据分析

第 11 章植物基因体学市场（按应用）

  • 农业
    • 抗病性
    • 遗传改良
    • 产量提高
  • 诊断
    • 基因检测
    • 传染病检查
    • 产前检查
  • 调查
    • 基础研究
    • 生物标记发现
    • 药物研发

第 12 章植物基因体学市场（按最终用户）

  • 学术研究机构
  • 农业企业
  • 医院和诊断实验室
  • 製药和生物技术公司

第十三章植物基因体学市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章植物基因体学市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按国家/地区分類的植物基因组学市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • BGI Genomics Co., Ltd.
    • QIAGEN NV
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies Limited
    • Eurofins Scientific SE
    • Merck KGaA
Product Code: MRR-4316E4E8911B

The Plant Genomics Market is projected to grow by USD 23.09 billion at a CAGR of 9.50% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 11.16 billion
Estimated Year [2025] USD 12.23 billion
Forecast Year [2032] USD 23.09 billion
CAGR (%) 9.50%

A strategic primer on plant genomics that frames technological integration, operational priorities, and stakeholder needs across agriculture, diagnostics, and research

Plant genomics stands at the intersection of biology, data science, and agricultural innovation, and its expanding toolkit is redefining how stakeholders pursue productivity, resilience, and diagnostic insight. Advances in editing platforms, amplification techniques, and sequencing technologies have progressively lowered technical barriers, enabling a broader set of organizations to integrate genomics into breeding programs, diagnostic workflows, and foundational research. This shift is accompanied by a growing emphasis on data management, reproducibility, and regulatory clarity, which together shape investment priorities and operational choices across the value chain.

As the discipline matures, practitioners are navigating increasingly complex supplier networks, evolving standards for genetic tool deployment, and a heightened demand for robust bioinformatics pipelines. In response, cross-disciplinary teams are reorganizing around modular workflows that connect instruments, reagents, analytical software, and services. This integrated approach enhances throughput and interpretability, while also highlighting the need for adaptable procurement strategies and skilled personnel who can translate genomic outputs into actionable decisions for agriculture, diagnostics, and discovery research.

How technological breakthroughs, evolving regulatory expectations, and service-centric models are reshaping strategic priorities and operational workflows in plant genomics

The plant genomics landscape is experiencing transformative shifts driven by methodological breakthroughs, changes in regulatory postures, and evolving end-user expectations. Gene editing technologies have moved from niche experimental tools to practical instruments for trait development, prompting downstream adjustments in breeding strategies and intellectual property management. At the same time, sequencing platforms are delivering richer and more complex datasets, requiring investment in scalable storage, standardized data formats, and analytical frameworks that can support cross-study comparisons and translational applications.

Concurrently, services and software are gaining prominence as organizations prioritize outcomes over in-house instrumentation. This trend encourages collaborative models that pair specialized wet-lab capabilities with advanced computational offerings. Supply chain resilience and sourcing transparency are elevated concerns, prompting a reconsideration of procurement practices. Taken together, these forces are reshaping how organizations allocate capital, design experiments, and structure partnerships, emphasizing agility and downstream value realization over isolated technology acquisition.

Assessing the operational and logistical ripple effects of recent tariff measures on procurement, collaboration, and supply continuity within plant genomics workflows

Recent tariff measures affecting imports and exports have introduced new frictions across the plant genomics ecosystem, influencing procurement of instruments, reagents, and software licensing. For laboratories that rely on cross-border supply of sequencing instruments and specialized reagents, tariff-related cost adjustments can translate into altered procurement timelines and modified capital planning. These dynamics, in turn, affect laboratory throughput and the pace at which new projects are initiated, particularly for organizations operating on tight grant cycles or seasonal agricultural timelines.

Beyond direct cost impacts, tariffs can complicate collaborative research arrangements that depend on timely shipment of samples, consumables, or modular instrument components. As a result, teams increasingly consider regional sourcing alternatives, longer lead times, and contractual safeguards to preserve research continuity. Trade measures also raise the profile of localized manufacturing and distribution strategies, which some stakeholders pursue to mitigate exposure. Importantly, regulatory and customs processes tied to tariff implementation can lengthen clearance times for biological materials and hardware, thereby creating operational bottlenecks that require proactive logistical planning and transparent supplier communication to manage.

Deep segmentation insights revealing how product types, technology platforms, service models, applications, and end users create differentiated value pools across plant genomics

A nuanced understanding of market segmentation clarifies where value is created and which capabilities merit investment. Based on product type, stakeholders classify offerings among instruments, reagents and consumables, services, and software, each carrying distinct procurement cycles and support expectations. Instruments require capital planning and long-term service agreements, reagents and consumables drive recurring spend and quality control concerns, services deliver outcome-oriented capacity for labs lacking in-house capability, and software underpins data processing, visualization, and decision support.

Based on technology, the domain encompasses gene editing, polymerase chain reaction, and sequencing platforms. Gene editing itself is differentiated by CRISPR, transcription activator-like effector nucleases, and zinc finger nucleases, each varying in specificity, delivery approaches, and regulatory scrutiny. Polymerase chain reaction modalities include digital PCR, quantitative PCR, and reverse transcription PCR, which serve distinct applications from absolute quantitation to expression analysis. Sequencing technologies span next-generation, Sanger, and third-generation modalities, offering trade-offs among read length, throughput, and error profiles.

Based on service model, organizations rely on consulting, contract research, and data analysis to augment internal capabilities and accelerate project timelines. These models enable access to specialized expertise and infrastructure without the fixed costs of full ownership. Based on application, use cases map to agriculture, diagnostics, and research. Agricultural applications focus on disease resistance, genetic improvement, and yield enhancement, while diagnostics emphasize genetic testing, infectious disease testing, and prenatal testing. Research spans basic inquiry, biomarker discovery, and drug discovery, each demanding different experimental designs and validation pathways. Based on end users, adoption patterns are driven by academic and research institutes, agricultural firms, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology companies, with each group prioritizing different performance attributes, compliance needs, and service expectations.

Regional dynamics and strategic implications across the Americas, Europe-Middle East-Africa, and Asia-Pacific that influence adoption, regulation, and infrastructure choices

Regional dynamics shape access to talent, capital infrastructure, and regulatory frameworks, and three geographic clusters merit focused attention. The Americas region exhibits a diverse mix of academic excellence, venture activity, and established industrial players, supporting rapid translation of genomic tools into commercial pipelines. Infrastructure strength and proximity to large agricultural markets encourage adoption of both high-throughput sequencing and applied gene editing programs, while regional regulatory processes influence trial design and product deployment.

Europe, the Middle East, and Africa present a varied landscape with progressive research hubs, differentiated regulatory environments, and distinct agricultural priorities. Fragmentation across jurisdictions creates both challenges and opportunities: harmonized regulatory approaches can accelerate cross-border collaborations, whereas divergent rules incentivize localized strategies and partnerships with regional service providers. Meanwhile, parts of the region emphasize sustainable agriculture and biodiversity conservation, which affects research agendas and stakeholder engagement models.

Asia-Pacific is characterized by fast-growing R&D investments, an expanding base of skilled practitioners, and strong governmental initiatives to modernize agriculture and public health diagnostics. Supply chain integration across manufacturing hubs and end-user markets enables scale advantages for reagent and instrument suppliers, while national policies around biotechnology and biosafety shape permissible applications and commercialization pathways. Each region's unique mix of scientific capacity, policy orientation, and market demand requires tailored go-to-market approaches and localized partnerships to maximize impact.

Competitive dynamics and strategic playbooks that highlight platform integration, service bundling, and data governance as differentiators among plant genomics providers

Leading players in the plant genomics ecosystem differentiate themselves through integrated portfolios that combine instrumentation, consumables, software, and service offerings. Companies that align product roadmaps with user workflows and emphasize interoperability tend to reduce adoption friction and increase customer lifetime engagement. Strategic partnerships between instrument manufacturers, reagent suppliers, and specialized service providers create bundled solutions that appeal to organizations seeking turnkey capabilities.

Innovation pathways often center on platform scalability, ease of use, and data integration. Vendors who provide robust training, certification, and application support lower the barrier to adoption in non-traditional end users, such as agricultural firms with limited molecular biology experience. Additionally, firms that invest in secure, compliant cloud environments and transparent data governance practices address a growing set of buyer concerns related to data residency and reproducibility. Contract research organizations and consulting providers that can demonstrate reproducible project outcomes and flexible delivery models are increasingly selected by clients prioritizing speed to insight over capital investment in new instrumentation.

Practical and prioritized actions for leaders to strengthen supply resilience, scale operations, and align commercial models with evolving user needs

Industry leaders should pursue a set of actionable priorities that balance near-term resilience with long-term capability building. First, diversifying supply chains and qualifying multiple vetted suppliers for critical reagents and instrument components will reduce operational disruption and support continuity during tariff-driven market shifts. Second, investing in modular automation and standardized data pipelines enhances throughput while lowering the personnel burden of routine processes, thereby improving reproducibility and enabling scale.

Third, deepen collaborations with regional partners and contract research providers to access local expertise, share risk, and accelerate project timelines without overcommitting fixed capital. Fourth, prioritize transparent data governance and cybersecurity measures to build trust with end users and satisfy evolving regulatory requirements. Fifth, design flexible commercial models that combine hardware, consumables, and outcome-oriented services to meet diverse buyer preferences. Finally, build cross-functional teams that integrate domain scientists, bioinformaticians, and regulatory specialists to ensure that product development and deployment decisions align with real-world operational constraints and stakeholder expectations.

A rigorous mixed-method research approach combining expert interviews, technical literature review, and iterative validation to ensure practical and actionable insights

The research methodology combines qualitative and quantitative approaches to ensure robustness and relevance. Primary inputs include structured interviews with domain experts across academia, industry, and clinical settings, alongside consultations with laboratory operations managers and procurement specialists to validate operational constraints and purchasing behaviors. Secondary inputs encompass peer-reviewed literature, regulatory documents, technical white papers, and publicly available product specifications, which together provide a technical baseline for comparative assessment.

Data triangulation was applied to reconcile insights from diverse sources, and thematic analysis identified recurrent operational challenges, technology adoption drivers, and supplier positioning. Throughout the process, iterative validation sessions with subject matter experts refined interpretations and ensured that practical considerations-such as reagent lifecycle management, instrument calibration needs, and data interoperability requirements-were accurately represented. The resulting framework integrates product, technology, service, application, and end-user perspectives to support decision making without relying on single-source assumptions.

Synthesis of practical implications and strategic priorities that leaders must address to convert plant genomics advancements into reliable operational and commercial outcomes

The collective evidence highlights a plant genomics ecosystem in transition, where technological maturity, data complexity, and supply chain considerations intersect to redefine strategic priorities. Stakeholders who invest in interoperable platforms, resilient procurement models, and outcome-oriented service partnerships are better positioned to translate genomic capabilities into operational impact. Equally important is the cultivation of multidisciplinary teams that can bridge wet-lab execution with bioinformatic interpretation and regulatory navigation.

Looking ahead, success will be determined less by single technology choices and more by the ability to assemble adaptable workflows that meet specific application needs, whether in agriculture, diagnostics, or foundational research. Organizations that balance near-term operational resilience with long-term investments in automation, data governance, and regional partnerships will navigate present challenges while preserving optionality to capitalize on future innovations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advancements in CRISPR-Cas mediated gene editing for drought-resistant crop varieties enabling climate adaptation
  • 5.2. Integration of artificial intelligence and machine learning to accelerate plant trait discovery processes
  • 5.3. Development of high-throughput single-cell sequencing platforms for plant stress response profiling
  • 5.4. Commercialization of precision gene-editing technologies to enhance crop yield and nutritional content
  • 5.5. Implementation of pan-genome analysis to uncover genetic diversity in major cereal crops
  • 5.6. Application of targeted epigenome editing tools to regulate plant growth and environmental resilience
  • 5.7. Utilization of integrated multi-omics data to predict complex trait inheritance in breeding programs
  • 5.8. Expansion of synthetic biology approaches to engineer photosynthetic efficiency in staple crops
  • 5.9. Adoption of portable nanopore sequencing systems for real-time pathogen detection in agricultural fields
  • 5.10. Global regulatory harmonization efforts influencing acceptance of genetically modified plant products

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Plant Genomics Market, by Product Type

  • 8.1. Instruments
  • 8.2. Reagents & Consumables
  • 8.3. Services
  • 8.4. Software

9. Plant Genomics Market, by Technology

  • 9.1. Gene Editing
    • 9.1.1. Crispr
    • 9.1.2. Transcription Activator Like Effector Nucleases
    • 9.1.3. Zinc Finger Nucleases
  • 9.2. Polymerase Chain Reaction
    • 9.2.1. Digital Polymerase Chain Reaction
    • 9.2.2. Quantitative Polymerase Chain Reaction
    • 9.2.3. Reverse Transcription Polymerase Chain Reaction
  • 9.3. Sequencing
    • 9.3.1. Next Generation Sequencing
    • 9.3.2. Sanger Sequencing
    • 9.3.3. Third Generation Sequencing

10. Plant Genomics Market, by Service Model

  • 10.1. Consulting
  • 10.2. Contract Research
  • 10.3. Data Analysis

11. Plant Genomics Market, by Application

  • 11.1. Agriculture
    • 11.1.1. Disease Resistance
    • 11.1.2. Genetic Improvement
    • 11.1.3. Yield Improvement
  • 11.2. Diagnostics
    • 11.2.1. Genetic Testing
    • 11.2.2. Infectious Disease Testing
    • 11.2.3. Prenatal Testing
  • 11.3. Research
    • 11.3.1. Basic Research
    • 11.3.2. Biomarker Discovery
    • 11.3.3. Drug Discovery

12. Plant Genomics Market, by End Users

  • 12.1. Academic & Research Institutes
  • 12.2. Agriculture Firms
  • 12.3. Hospitals & Diagnostic Laboratories
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Plant Genomics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Plant Genomics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Plant Genomics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Illumina, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. BGI Genomics Co., Ltd.
    • 16.3.4. QIAGEN N.V.
    • 16.3.5. Agilent Technologies, Inc.
    • 16.3.6. PerkinElmer, Inc.
    • 16.3.7. Pacific Biosciences of California, Inc.
    • 16.3.8. Oxford Nanopore Technologies Limited
    • 16.3.9. Eurofins Scientific SE
    • 16.3.10. Merck KGaA

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PLANT GENOMICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PLANT GENOMICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PLANT GENOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PLANT GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PLANT GENOMICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PLANT GENOMICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY AP